BrightPath Biotherapeutics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Public

  • Employees
  • 23

Employees

  • Stock Symbol
  • 4594

Stock Symbol

  • Share Price
  • $0.24
  • (As of Wednesday Closing)

BrightPath Biotherapeutics General Information

Description

BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

Contact Information

Formerly Known As
GreenPeptide Co., Ltd., GreenPeptide
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Fukuoka Bio Incubation Center, 1-1 Hyakunenkoen
  • Kurume-shi
  • Fukuoka, 839-0864
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Vertical(s)
Corporate Office
  • Fukuoka Bio Incubation Center, 1-1 Hyakunenkoen
  • Kurume-shi
  • Fukuoka, 839-0864
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BrightPath Biotherapeutics Stock Performance

As of 18-Nov-2026, BrightPath Biotherapeutics’s stock price is $0.24. Its current market cap is $33.1M with 139M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.24 $0.24 $0.23 - $0.60 $33.1M 139M 1.39M -$0.08

BrightPath Biotherapeutics Financials Summary

As of 30-Jun-2026, BrightPath Biotherapeutics has a trailing 12-month revenue of $401.52.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 26,139 42,172 17,803 23,229
Revenue 1 1 7 1
EBITDA (8,642) (7,537) (8,068)
Net Income (10,321) (8,658) (7,549) (8,084)
Total Assets 12,503 16,295 7,489 8,129
Total Debt 0 167 743
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BrightPath Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BrightPath Biotherapeutics‘s full profile, request access.

Request a free trial

BrightPath Biotherapeutics Patents

BrightPath Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026133840-A1 Method for producing nkt cells, and nkt cell preparation production kit Pending 17-Dec-2024
WO-2025141875-A1 Method for producing tumor-reactive t cell Inactive 28-Dec-2023
WO-2025070636-A1 Multispecific antigen-binding molecule targeting cd39 Inactive 26-Sep-2023
JP-2024012879-A Method for producing tumor-reactive t-cell Active 19-Jul-2022
EP-4506368-A1 Bispecific antibody to human tim-3 and human cd39, and applications thereof Pending 07-Apr-2022 G01N33/5011
To view BrightPath Biotherapeutics’s complete patent history, request access »

BrightPath Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BrightPath Biotherapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view BrightPath Biotherapeutics’s complete esg history, request access »

BrightPath Biotherapeutics FAQs

  • When was BrightPath Biotherapeutics founded?

    BrightPath Biotherapeutics was founded in 2003.

  • Where is BrightPath Biotherapeutics headquartered?

    BrightPath Biotherapeutics is headquartered in Fukuoka, Japan.

  • What is the size of BrightPath Biotherapeutics?

    BrightPath Biotherapeutics has 23 total employees.

  • What industry is BrightPath Biotherapeutics in?

    BrightPath Biotherapeutics’s primary industry is Drug Discovery.

  • Is BrightPath Biotherapeutics a private or public company?

    BrightPath Biotherapeutics is a Public company.

  • What is BrightPath Biotherapeutics’s stock symbol?

    The ticker symbol for BrightPath Biotherapeutics is 4594.

  • What is the current stock price of BrightPath Biotherapeutics?

    As of 18-Nov-2026 the stock price of BrightPath Biotherapeutics is $0.24.

  • What is the current market cap of BrightPath Biotherapeutics?

    The current market capitalization of BrightPath Biotherapeutics is $33.1M.

  • What is BrightPath Biotherapeutics’s current revenue?

    The trailing twelve month revenue for BrightPath Biotherapeutics is $401.52.

  • What is BrightPath Biotherapeutics’s annual earnings per share (EPS)?

    BrightPath Biotherapeutics’s EPS for 12 months was -$0.08.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process